
Dapagliflozin (10mg) + Sitagliptin (100mg) + Metformin (1000mg)
Active composition
+2 more active ingredients
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Emildap Trio Forte Tablet ER is a combination medication that contains Dapagliflozin, Metformin, and Sitagliptin designed to support effective blood glucose management. Dapagliflozin works by preventing the kidneys from reabsorbing excess glucose so that it can be removed through urine. Metformin helps reduce the production of glucose in the liver and improves insulin sensitivity in the body. Sitagliptin enhances the activity of hormones that help regulate insulin secretion and control blood sugar levels after meals. The extended release formulation allows the medicine to release gradually for long lasting action. Together these medicines help provide better glycemic control and support stable blood sugar levels throughout the day. Maintaining controlled glucose levels is essential for preventing diabetes related complications and supporting overall metabolic health. This medicine is usually used along with proper diet and regular physical activity. When taken as prescribed by a healthcare professional, Emildap Trio Forte Tablet ER helps maintain effective blood sugar control.
How to use Emildap Trio Tablet ER Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Emildap Trio Forte Tablet ER may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is not known whether it is safe to consume alcohol with Emildap Trio Forte Tablet ER. Please consult your doctor.
High Risk
Information regarding the use of Emildap Trio Forte Tablet ER during pregnancy is not available. Please consult your doctor.
Medical Advice
Emildap Trio Forte Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
There is limited information available on the use of Emildap Trio Forte Tablet ER in patients with liver disease. Please consult your doctor.
Regular Checkup
Information regarding the use of Emildap Trio Forte Tablet ER during breastfeeding is not available. Please consult your doctor.
Consult Doctor
Emildap Trio Forte Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Emildap Trio Forte Tablet ER may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Emildap Trio Forte Tablet ER

Dapagliflozin (10mg) + Metformin (1000mg) + Sitagliptin (100mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+2 more active ingredients
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Emildap Trio Forte Tablet ER is a combination medication that contains Dapagliflozin, Metformin, and Sitagliptin designed to support effective blood glucose management. Dapagliflozin works by preventing the kidneys from reabsorbing excess glucose so that it can be removed through urine. Metformin helps reduce the production of glucose in the liver and improves insulin sensitivity in the body. Sitagliptin enhances the activity of hormones that help regulate insulin secretion and control blood sugar levels after meals. The extended release formulation allows the medicine to release gradually for long lasting action. Together these medicines help provide better glycemic control and support stable blood sugar levels throughout the day. Maintaining controlled glucose levels is essential for preventing diabetes related complications and supporting overall metabolic health. This medicine is usually used along with proper diet and regular physical activity. When taken as prescribed by a healthcare professional, Emildap Trio Forte Tablet ER helps maintain effective blood sugar control.
How to use Emildap Trio Tablet ER Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Emildap Trio Forte Tablet ER may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is not known whether it is safe to consume alcohol with Emildap Trio Forte Tablet ER. Please consult your doctor.
High Risk
Information regarding the use of Emildap Trio Forte Tablet ER during pregnancy is not available. Please consult your doctor.
Medical Advice
Emildap Trio Forte Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
There is limited information available on the use of Emildap Trio Forte Tablet ER in patients with liver disease. Please consult your doctor.
Regular Checkup
Information regarding the use of Emildap Trio Forte Tablet ER during breastfeeding is not available. Please consult your doctor.
Consult Doctor
Emildap Trio Forte Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Emildap Trio Forte Tablet ER may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Emildap Trio Forte Tablet ER













